ng/mL, 3 6 0.6 ng/mL and 1.7 6 0.3 ng/mL accordingly). BMI was considerably associated with BA severity (R ¼ 0.4) and IgE-autoreactivity only in obese asthmatics (R ¼ 0.58; P ¼ 0.01), which showed raised IgEautoAbs to keratin (11.6 6 2 IU/mL) and collagen III (1.03 6 0.3 IU/mL) in comparison with preobese (6.7 6 1.5 IU/mL, 0.3 6 0.01 IU/mL) and nonobese patients. The levels of total IgE in all groups showed no association with BMI and serum leptine concentration. Leptine level correlated with CRP (R ¼ 0.59) and BMI (R ¼ 0.4) and appeared to be overproduced in obese (57 6 7.1 ng/mL) via non-obese (23 6 6 ng/mL) asthmatics, as compared with AR patients and healthy subjects independently from BMI (6.1 6 0.3 ng/mL) and therefore was associated with BA but not atopy in overweight patients. Conclusions: In obese patients with atopy the adipose mass represents an important source of inflammatory cytokines whereas it's mediators, such as leptine appears to impact especially in pathogenesis of BA in comparison with AR. Obesity is attended with higher generation of autoIgE-Abs, which elevated levels can indicate the disturbance of normal immune regulation. So asthmatics with higher BMI, show a special phenotype of disease which needs to be managed and treated distinctly. We analyzed 215 bronchoprovocation challenges of adolescents from 10 to 18 years old in the period 2006 to 2010. We classified them in 3 groups: eutrophic (BMI , p85), obese (BMI p90-99) and morbid obeses (BMI . p99) without smoking contact of pulmonar disease. A basal spirometry was performed according to the ATS guidelines. If the FEV 1 was above 80% for age and gender we performed the methacholine challenge. We use the dosimeter method with the following methacholine dilutions: 0.0625 mg, 0.25 mg, 1 mg, 4 mg and 16 mg. When a provocation concentration caused a 20% FEV 1 reduced was considered a positive challenge for bronchial hyperresponsiveness (BHR). Results: Of the 215 adolescents in this study: 40 were eutrophic, 116 obese and 59 morbid obese. The methacholine challenges were positive in 12% of eutrophic, 22% of morbid obese and 25% of obese. But there were not a statistically significant difference. Gender was not associated as a risk factor for bronchial hyperresponsiveness. The positive bronchoprovation challege in women was observed in 27.6% of morbid obese, 23.7% of obese and 5% of eutrophic; in men 26.3% of obese, 20% of eutrophic and 16.7% of morbid obese. There was not a stadistically significant difference. Conclusions: It is necessary a larger number of patients to concluded that BMI and gender are not associated with increased bronchial hyperresponsivess. Background: Bronchial hyperresponsiveness (BHR) is an important pathophysiological feature of asthma. In addition to the diagnostic significance, BHR is associated with the severity of airway inflammation and BHR-based treatment approaches has been shown to be effective. Nevertheless, challenge tests are time consuming, inconvenient to patients, and are not accessible in every primary care physicians. We aimed to develop a questionnaire for the assessment of BHR in Korean subjects. Methods: From the 24 University-affiliated hospitals, we recruited 149 adults between age 20 and 40 years with more than one asthmatic symptom (cough, sputum or dyspnea) and who had bronchial provocation test. A list of 33 symptoms, past history of allergy or smoking and 10 provoking stimuli were selected for the BHR questionnaire. After a methacholine challenge test patients were asked to complete each questionnaire. For each item of questionnaire, diagnostic odds ratios for the presence of BHR were calculated and multiple logistic regression analysis was performed to select final questionnaire items. Receiver operating characteristic (ROC) curve analysis was used to evaluate the sensitivity and specificity of the selected questionnaire items. Results: Methacholine challenge test was positive in 36 patients (24.2%). Eleven symptoms and 2 provoking stimuli items were statistically significant by the results of diagnostic odds ratio. According to the result of multiple logistic regression analysis, 4 items were finally selected for the significant BHR questionnaire: the presence of wheezing episode, past history of physician-diagnosed asthma, family history of asthma. The psychiatric stress was negatively associated provoking stimuli item for the presence of BHR. The area under the ROC curve was 0.80 (95% CI, 0.72-0.86). Sensitivity was 84.9% (95% CI, 68.1-94.9) and specificity was 65.5% (95% CI, 55.8-74.3). Conclusions: Four BHR questionnaire items including wheezing episode, past history of physician-diagnosed asthma, family history of asthma and psyachiatric stress stimuli were able to assess the presence of BHR in Korean adults.
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Bronchial Hyperresponsiveness in Obese Adolescents
Gabriela Ramírez, MD, and Blanca del Rio, MD. Pediatric Allergy and Clinical Immunology, Hospital Infantil de México Federico Gómez, México City, Mexico. Background: Identify the frequency of bronchial hyperresponsiveness in the obese and morbid obese adolescent. Compare the results of the direct challenge with gender and BMI. Methods: We analyzed 215 bronchoprovocation challenges of adolescents from 10 to 18 years old in the period 2006 to 2010. We classified them in 3 groups: eutrophic (BMI , p85), obese (BMI p90-99) and morbid obeses (BMI . p99) without smoking contact of pulmonar disease. A basal spirometry was performed according to the ATS guidelines. If the FEV 1 was above 80% for age and gender we performed the methacholine challenge. We use the dosimeter method with the following methacholine dilutions: 0.0625 mg, 0.25 mg, 1 mg, 4 mg and 16 mg. When a provocation concentration caused a 20% FEV 1 reduced was considered a positive challenge for bronchial hyperresponsiveness (BHR). Results: Of the 215 adolescents in this study: 40 were eutrophic, 116 obese and 59 morbid obese. The methacholine challenges were positive in 12% of eutrophic, 22% of morbid obese and 25% of obese. But there were not a statistically significant difference. Gender was not associated as a risk factor for bronchial hyperresponsiveness. The positive bronchoprovation challege in women was observed in 27.6% of morbid obese, 23.7% of obese and 5% of eutrophic; in men 26.3% of obese, 20% of eutrophic and 16.7% of morbid obese. There was not a stadistically significant difference. Conclusions: It is necessary a larger number of patients to concluded that BMI and gender are not associated with increased bronchial hyperresponsivess. Background: Bronchial hyperresponsiveness (BHR) is an important pathophysiological feature of asthma. In addition to the diagnostic significance, BHR is associated with the severity of airway inflammation and BHR-based treatment approaches has been shown to be effective. Nevertheless, challenge tests are time consuming, inconvenient to patients, and are not accessible in every primary care physicians. We aimed to develop a questionnaire for the assessment of BHR in Korean subjects. Methods: From the 24 University-affiliated hospitals, we recruited 149 adults between age 20 and 40 years with more than one asthmatic symptom (cough, sputum or dyspnea) and who had bronchial provocation test. A list of 33 symptoms, past history of allergy or smoking and 10 provoking stimuli were selected for the BHR questionnaire. After a methacholine challenge test patients were asked to complete each questionnaire. For each item of questionnaire, diagnostic odds ratios for the presence of BHR were calculated and multiple logistic regression analysis was performed to select final questionnaire items. Receiver operating characteristic (ROC) curve analysis was used to evaluate the sensitivity and specificity of the selected questionnaire items. Results: Methacholine challenge test was positive in 36 patients (24.2%). Eleven symptoms and 2 provoking stimuli items were statistically significant by the results of diagnostic odds ratio. According to the result of multiple logistic regression analysis, 4 items were finally selected for the significant BHR questionnaire: the presence of wheezing episode, past history of physician-diagnosed asthma, family history of asthma. The psychiatric stress was negatively associated provoking stimuli item for the presence of BHR. The area under the ROC curve was 0.80 (95% CI, 0.72-0.86). Sensitivity was 84.9% (95% CI, 68.1-94.9) and specificity was 65.5% (95% CI, 55.8-74.3). Conclusions: Four BHR questionnaire items including wheezing episode, past history of physician-diagnosed asthma, family history of asthma and psyachiatric stress stimuli were able to assess the presence of BHR in Korean adults.
Clinical Analysis of Salbutamol Responsiveness after Acetylcholine-induced Bronchoconstriction in Childhood Asthma
Tomio Kondo, MD, PhD, 1 Yoshiki Nakashima, MD, PhD, 2 and Hiroaki Shikano, MD, PhD 2 . 1 Department of Pediatrics, Hirano General Hospital, Gifu-city, Japan; 2 Department of Pediatrics, Ogaki Municipal Hospital, Ogaki-city, Japan. Background: The bronchodilator is usually inhaled after the acethylcholine (Ach) inhalation test for asthmatic patients. We investigated clinical characteristics of asthma about the response to a inhalation of salbutamol after the Ach provocation test. Methods: Asthmatic patients from 6 to 18 years old were examined. They inhaled aerosol with increased concentration of Ach to produce 20% or more decrease in FEV1.0 (RT-Ach point). After then they inhaled salbutamol, and respiratory function was examined after 0, 5, 10, and 15 minutes. We divided the patient into 4 groups (G0,G5,G10,G15) by the recovery time up to baseline FEV1.0 after inhalation of salbutamol. Results: Pre-provocated baseline FEV1.0, the rate of actual FEV1.0 /predictive FEV1.0, RT-Ach and FEV1.0 at the point of RT-Ach were lower in the G0 than other groups significantly. Complication of exercise induced asthma (EIA) and increased rate of FVC after the inhalation of salbutamol were higher in the G0. Serum IgE, eosinophil count of peripheral blood was not different in these groups. Conclusions: We investigated about the response to salbutamol after the provocation of Ach for childhood asthma. Bronchial constriction and hyperresponsiveness exit prior to challenge Ach in the group of early response to b2-agonist after the provocation test. Results: Postoperative complications are associated with prolonged hospital stays and excessive morbidity and mortality especially in this group of patients. According to the ACCP/BTS guidelines, patients without known underlying lung disease with a preoperative FEV1 in excess of 2 L, generally tolerate pneumonectomy whereas those with FEV1 greater that 1.5 L, tolerate lobectomy. Although spirometric values strongly correlate with the severity of obstruction, they do not provide direct information regarding the degree of gas exchange impairment or the status of cardiovascular function. Cardiopulmonary exercise testing (CPET) is a preoperative test suggested before lung resection in patients with known underlying cardiovascular or lung disease. It is based on the interactions among pulmonary function, cardiovascular function and oxygen absorption from the peripheral tissues. Patients with maximal oxygen consumption (VO 2 max) ,10 mL/kg/min or those with VO 2 max , 15 mL/kg/min and both postoperative predicted FEV1 and DLCO ,40% are considered to be at high risk of perioperative death and cardiopulmonary complications postoperatively. Studies have shown that oxygen uptake efficiency slope, oxygen pulse and heart rate at peak exercise are correlated with better postoperative outcome. Conclusions: Further research is required to elucidate the role of CPET in the preoperative evaluation of this group of patients.
Annual Change of Peak Expiratory Flow Rate in Asthma and COPD
Kwang H. A. Yoo, MD, PhD, and Kye Young Lee, MD, PhD. Internal Medicine, Konkuk University Medical Center, Seoul, South Korea. Background: Peak Expiratory Flow Rate (PEFR) is a useful measurement for the follow-up examination in a chronic airway disease because it has the advantage of simple measuring and repetitive examination. The aim of this study is to examine the annual decrease of PEFR in asthma and COPD patients and to confirm the factors which influence the annual decreasing rate of PEFR. Methods: From May, 2003 to September, 2010, the annual decreasing rate of PEFR is obtained from the asthma and COPD patients attending an outpatient pulmonary clinic. PEFR was measured using Mini-Wright (Clement Clarke International Ltd. UK). We conducted an analysis of the factors to influence on the change of PEFR and the average of it. Results: The result indicated decrease of 3.72 6 12.55 L/min annually in the asthmatic patient and decrease of 8.69 6 8.87 L/min annually in the COPD patient. In the asthma, age and FEV1 are the predictive factor to influence on the change, on the other hand, age, FEV1, smoking and the number of aggravation are the factors in the COPD. Conclusions: We could confirm the annual decreasing rate in patients of chronic airway disease and similar factor with FEV1 to influence on the change. Asthma is an inflammatory disease of the airways. The pathophysiological effects of airway obstruction include air trapping and dynamic hyperinflation. The investigation of asthma is usually performed through pulmonary function tests. The assessment of asthma by radiological methods is required to rule out other causes of bronchospasm or out complications. The aim of this study was to evaluate the changes found in the chest computed tomography (CT) in patients with persistent asthma. Methods: Sixty-nine patients of both genders and above 18 years of age, accompanied by persistent asthma, participated in the study. The charts were analyzed for severity and onset of symptoms of asthma, spirometry, search of specific IgE and chest tomography. Results: The mean age was 55.7 years, 71% female. Asthma began in childhood in 55.8% of patients. All patients had persistent asthma, divided into 66.7% of severe asthma, 29% moderate and only 4.3% mild. Only 14.5% of spirometry was normal. Atopy, assessed by clinical history and research of specific IgE was observed in 75.8% of patients. Regarding CT scans of the chest, the primary findings were bronchial wall thickening in 70% of patients, nodules in 25%, and atelectasis in 25%. The bronchiectasis was present in 20% of CT scans of the chest, and signs of emphysema in 10% of them. Conclusions: In this trial, the CT scans of the chest were primarily indicated for patients with severe persistent allergic asthma. Bronchiectasis was found in 20% of tests, suggesting that CT scan of the chest should be required for patients with partial response to conventional treatment, mainly in patients with severe asthma. Background: Exercise-induced (EI) symptoms may be associated with bronchospasm (EI-B), or laryngospasm, that is a paradoxical VC adduction (VCD) mimicking asthma. We previously found that vitamin D deficiency (Ddef) favours the occurrence of VCD during hyperventilation test (HV), particularly in hypocapnic conditions. We evaluated the occurrence of EI-B and EI-VCD during HV in relationship with Ddef, in 37 non smoking young athletes (24 males, 13 females, age: 13-25 years). Methods: Each subject underwent HV (5 runs of one minute) either in isocapnia (HViso, obtained breathing CO2 enriched air) or in hypocapnia (HVhypo, obtained breathing normal air) in randomized order, one week apart. Exhaled CO2 pressure was controlled breath by breath by a capnograph. A 10% decrease in FEV1 was used as EI-B marker, a 25% decrease in MIF50 as EI-VCD marker.
